期刊文献+

血清心肌肌钙蛋白T在冠心病介入治疗前后的变化与预后的关系 被引量:7

The Change of Serum Cardiac Troponin T Levels in Coronary Heart Disease before and after Interventional Therapy and Its Relationship with Prognosis
下载PDF
导出
摘要 观察经皮冠状动脉介入治疗(PCI)术前后血清心肌肌钙蛋白T(cTnT)表达水平,探讨其与预后之间相关关系。80例冠心病患者均接受PCI,于术前、术后测定血清cTnT水平进行比较。冠心病患者PCI术后血清cTnT水平均明显升高(P<0.05)。术前血清cTnT水平≥0.1ng/ml组患者心血管事件发生率更高(P<0.05)。术后24h血清cTnT水平≥0.1ng/ml组心血管不良事件总发生率为25例(47.2%),显著高于D组5例(18.5%)(P<0.05)。术后cTnT水平升高≥2倍组心血管不良事件发生率更高(P<0.05)。PCI术后cTnT显著升高,且术前或者术后cTnT升高均对预测术后6个月心血管不良事件发生率具有一定价值。 To observe the changes of serum cardiac troponin T in patients with coronary heart disease (CHD) before and after percutaneous coronary intervention therapy, and to investigate the relationship with prognosis. 80 patients with the diagnosis of coronary heart disease were treated with PCI, both in the preoperative min and after extraction to determinate of serum level of cTnT to compare. The level of serum cTnT in patients with coronary heart disease after PCI was significantly higher (P〈0.05). The patients with preoperative serum cTnT levels≥0.1ng/ml had higher cardiovascular events (P〈0.05). The patients with postoperative serum cTnT levels≥0.1ng/ml incidence of adverse cardiovascular events was 25 cases (47.2%) and was higher than 5 cases (18.5%) of D group (P〈0.05). The patients with serum cTnT levels≥2 had higher cardiovascular events (P〈0.05). serum cardiac troponin T levels were significantly elevated in patients with coronary heart disease before and after percutaneous coronary intervention, and the level of serum cardiac troponin T before operation or after operation has predictive value for major adverse cardiovascular events 6 mouths after operation.
出处 《医学与哲学(B)》 2016年第1期30-32,共3页 Medicine & Philosophy(B)
关键词 冠心病 经皮冠状动脉介入治疗 心肌肌钙蛋白T 预后 coronary heart disease, percutaneous coronarY interventionl, cardiac troponin T, prognosis
  • 相关文献

参考文献17

  • 1Xia J,Qu Y,Shen H,et al. Patients with stable coronary artery dis- ease receiving chronic statin treatment who are undergoing noncar- diac emergency surgery benefit from acute atorvastatin reload[J]. Cardiology,2014,128(3):285-292.
  • 2Ong K L, Waters D D, Messig M,et al. patients with stable coro- nary artery disease treated with atorvastatin(from the treating to new targets study[J]-Am J Cardiol ,2014,113(10):1593-1598.
  • 3Ong K L,Waters D D,Messig M,et al. patients with stable coro- nary artery disease treated with atorvastatin(from the treating to new targets study[J]. Am J Cardiol,2014,113(10):1593-1598.
  • 4徐海涛.实时心肌声学造影结合多巴酚丁胺负荷对冠心病介入治疗前后心肌灌注的评价[J].中外医学研究,2015,13(15):39-41. 被引量:3
  • 5Ghaeli P, Vejdani S, Ariamanesh A,et al. Effect of Melatonin on Cardiac Injury after Primary Percutaneous Coronary Intervention:a Randomized Controlled Trial[J]. Iran J Pharm Res,2015,14(3):851-855.
  • 6Roghi A, Poggiali E, Duca L,et al. Role of Non-Transferrin-Bound Iron in the pathogenesis of cardiotoxicity in patients with ST-eleva- tion myocardial infarction assessed by Cardiac Magnetic Resonance Imaging[J]. Int J Cardiol,2015 ,23(8):326-332.
  • 7郑春娜,黄丽红.冠心病患者心率减速力与心率变异性的关联性探讨[J].医学与哲学(B),2015,36(3):36-37. 被引量:12
  • 8Kimura S, Sugiyama T,Hishikari K,et al. Association of Intravas- cular Ultrasound-and Optical Coherence Tomography-Assessed Coronary Plaque Morphology With Periprocedural Myocardial Inju- ry in Patients With Stable Angina Pectoris[J]. Circ J , 2015 ,79(9):1944-1953.
  • 9Kitamura M, Hata N,Takayama T,et al. Different characteristics of cardiac biomarkers to decide and predict the culprit lesions in pa- tients with suspicious acute coronary syndrome[J]. Heart Vessels, 2015,17(21):12-16.
  • 10Hoshi T,Sato A, Akiyama D,et al. Coronary high-intensity plaque on Tl-weighted magnetic resonance imaging and its association with myocardial injury after percutaneous coronary intervcntion[J], Eur Heart J,2015,36(29):1913-1922.

二级参考文献41

  • 1郭士遵,舒先红,潘翠珍,李延林,葛均波,陈灏珠.定量实时心肌声学造影结合小剂量多巴酚丁胺负荷试验在冠心病诊断中的应用价值[J].中华心血管病杂志,2005,33(5):419-424. 被引量:5
  • 2张立群,魏岗之.雌激素与心脑血管病关系的研究现状[J].中华医学杂志,2005,85(28):2012-2015. 被引量:15
  • 3Mosca L, Appel L J,Benjamin E J, et al. Evidence based guidelines for cardiovascular disease prevention in women I-J. Circulation, 2004,109(5) :672--693.
  • 4谭筱林.冠心病性别差异奥秘的探索及其意义[J].医学与哲学,1986,7(3):912.
  • 5Wild R A,Wu C,Curb J D,et al. Coronary heart disease events in the Women's Health Initiative hormone trials: effect modification by metabolic syndrome: a nested case control study within theWomen's Health Initiative randomized clinical trials[J]. Meno- pause, 2013,20(3) : 254-- 260.
  • 6Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Re port of The National Cholesterol Education Program (NCEP) Ex pert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel lid [J]. JAMA, 2001,285 (19) : 2486-- 2497.
  • 7黎卫华,李向平.性激素替代治疗在冠心病防治中的作用[J].医学与哲学:临床决策论坛,2007,28(7):34-36.
  • 8Johnston N, Schenck--Gustafsson K, Lagerqvist B. Are we using cardiovascular medications and coronary angiography appropriately in men and women with chest pain? [J]Eur Heart J, 2011,32 (11) 1331--1336.
  • 9Chhatriwalla AK, Amin AP, Kennedy KF, et al. Association between bleeding events and in-hospital mortality after percutaneons coronary intervention [ J ]. JAMA, 2013, 309 ( 10 ) : 1022-1029.
  • 10Kim YH, Lee JY, Ahn JM, et al. Impact of bleeding on subsequent early and late mortality after drug-eluting stent implantation[ J]. JACC Cardiovasc Interv,2011,4(4) :423-431.

共引文献47

同被引文献66

引证文献7

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部